PharmaShots | Incisive News in 3 Shots

Subscribe Now

Esophageal cancer

Coherus and Junshi's Toripalimab Receive the US FDA's Orphan Drug Designation for the Treatment of Esophageal Cancer

Coherus and Junshi's Toripalimab Receive the US FDA's Orphan Drug Designation for the Treatment of Esophageal Cancer

November 16, 2021

BeiGene and Novartis Report the US FDA's Acceptance of BLA for Tislelizumab to Treat Esophageal Squamous Cell Carcinoma

BeiGene and Novartis Report the US FDA's Acceptance of BLA for Tislelizumab to Treat Esophageal Squamous Cell Carcinoma

September 13, 2021

Almac Diagnostic Collaborates with Queen's University to Bring Personalized Chemotherapy for Esophageal Cancer

Almac Diagnostic Collaborates with Queen's University to Bring Personalized Chemotherapy for Esophageal Cancer

April 19, 2019

Merck Reports Improved Overall Survival Results of Keytruda (pembrolizumab) vs Chemotherapy in KEYNOTE-181 Study

Merck Reports Improved Overall Survival Results of Keytruda (pembrolizumab) vs Chemotherapy in KEYNOTE-181 Study

November 15, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us